Predictions
Regeneron Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€508.90
06.08.21
06.08.21
-
06.08.22
06.08.22
17.82%
06.08.22
06.08.22
Regeneron Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€508.90
06.08.21
06.08.21
-
06.08.22
06.08.22
17.82%
06.08.22
06.08.22
Regeneron Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€508.90
06.08.21
06.08.21
-
06.08.22
06.08.22
17.82%
06.08.22
06.08.22
Aurinia Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€9.95
05.08.21
05.08.21
-
05.08.22
05.08.22
23.44%
08.08.21
08.08.21
Could be worthwhile Investment >10% per year
Chemocentryx Inc.
Start price
Target price
Perf. (%)
€12.50
30.07.21
30.07.21
€10.00
30.07.22
30.07.22
142.00%
13.10.21
13.10.21
Lower EBIT Margin than peer group
Very low/no dividend yield expected
negative Cash Flow expected
Bad rating
Erytech Pharma S.A.
Start price
Target price
Perf. (%)
€5.10
30.07.21
30.07.21
-
30.07.22
30.07.22
2.55%
08.08.21
08.08.21
Risky Investment
Infinity Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€2.38
29.07.21
29.07.21
-
28.07.22
28.07.22
-72.64%
29.07.22
29.07.22
Probably not worthwhile Investment
High valuation
Revenue decline/stagnation expected
Sustainability is little important
Infinity Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€1.92
28.07.21
28.07.21
-
28.07.22
28.07.22
-25.00%
06.01.22
06.01.22
Probably not worthwhile Investment
High valuation
Infinity Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€1.76
28.07.21
28.07.21
-
28.07.22
28.07.22
35.23%
29.07.21
29.07.21
Probably not worthwhile Investment
High valuation
Revenue decline/stagnation expected
Sustainability is little important
Ardelyx Inc.
Start price
Target price
Perf. (%)
€1.32
26.07.21
26.07.21
-
26.07.22
26.07.22
-48.82%
27.07.22
27.07.22
Risky Investment
Trinity Biotech ADR
Start price
Target price
Perf. (%)
€1.66
26.07.21
26.07.21
-
26.07.22
26.07.22
-21.08%
27.07.22
27.07.22
Could be very worthwhile Investment >20% year
Valneva SE
Start price
Target price
Perf. (%)
€11.24
20.07.21
20.07.21
€20.00
20.07.22
20.07.22
116.90%
25.11.21
25.11.21
Could be worthwhile Investment >10% per year
Very valuable balance sheet
Chemocentryx Inc.
Start price
Target price
Perf. (%)
€14.10
13.07.21
13.07.21
€21.00
13.07.22
13.07.22
-10.78%
13.08.21
13.08.21
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Higher EBIT margin than peer group
Perrigo Co. plc
Start price
Target price
Perf. (%)
€39.00
13.07.21
13.07.21
-
13.07.22
13.07.22
-18.36%
02.05.22
02.05.22
Could be worthwhile Investment >10% per year
Undervalued
Higher risks for its business
Chemocentryx Inc.
Start price
Target price
Perf. (%)
€13.66
13.07.21
13.07.21
-
13.07.22
13.07.22
69.13%
14.07.22
14.07.22
Could be worthwhile Investment >10% per year
Standard Investments for future growth
Sustainability is important
High valuation
Biolife Solutions Inc
Start price
Target price
Perf. (%)
€40.84
13.07.21
13.07.21
-
13.07.22
13.07.22
-62.81%
13.07.22
13.07.22
Catalyst Pharmaceutical Partners Inc
Start price
Target price
Perf. (%)
€4.66
12.07.21
12.07.21
-
12.07.22
12.07.22
48.95%
13.03.22
13.03.22
Inovio Pharma
Start price
Target price
Perf. (%)
€6.92
10.07.21
10.07.21
€5.80
10.07.22
10.07.22
-6.86%
27.11.21
27.11.21
Very low/no dividend yield expected
Risky balance sheet
ROE lower than 10% per year
Increased challenges to pay loans and raise capital
Chemocentryx Inc.
Start price
Target price
Perf. (%)
€14.32
10.07.21
10.07.21
€20.00
10.07.22
10.07.22
-12.71%
30.07.21
30.07.21
Lower EBIT Margin than peer group
Very low/no dividend yield expected
negative Cash Flow expected
Bad rating
Pfizer Inc.
Start price
Target price
Perf. (%)
€33.31
09.07.21
09.07.21
-
09.07.22
09.07.22
0.27%
09.07.21
09.07.21
Top 10 in its market
Small cyclical dependencies
Pfizer Inc.
Start price
Target price
Perf. (%)
€33.31
09.07.21
09.07.21
-
09.07.22
09.07.22
0.27%
09.07.21
09.07.21
Top 10 in its market
Small cyclical dependencies
